Accuray (ARAY) Shares Outstanding (Weighted Average) (2010 - 2026)
Accuray (ARAY) reported Shares Outstanding (Weighted Average) of $121396.0 for Q1 2026, up 19.65% on a YoY basis from $101462.0 in Q1 2025, and little changed quarter-over-quarter from $120973.0 in Q4 2025.
Accuray (ARAY) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Accuray has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $121396.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 19.65% year-over-year to $121396.0; the trailing twelve-month figure through Mar 2026 stood at $121396.0 (up 19.65% YoY), and the FY2025 full-year result was $6.2 million, down 93.69% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $121396.0, roughly flat from $120973.0 in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $118.9 million in Q3 2025, with the low at $101405.0 in Q4 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $75.1 million across 5 years, with a median of $94.9 million in 2023.
- Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) sank 99.9% — and 2026, when it gained 19.65%.
- Accuray's Shares Outstanding (Weighted Average) stood at $94.0 million in 2022, then gained by 3.96% to $97.8 million in 2023, then tumbled by 99.9% to $101405.0 in 2024, then rose by 19.3% to $120973.0 in 2025, then advanced by 0.35% to $121396.0 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $121396.0 (Q1 2026), $120973.0 (Q4 2025), and $118.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | 121,396.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,396.00 |
| Dec 31, 2025 | 120,973.00 |
| Sep 30, 2025 | 118.95 Mn |
| Jun 30, 2025 | 102.77 Mn |
| Mar 31, 2025 | 101,462.00 |
| Dec 31, 2024 | 101,405.00 |
| Sep 30, 2024 | 100.23 Mn |
| Jun 30, 2024 | 98.27 Mn |
| Mar 31, 2024 | 99.20 Mn |
| Dec 31, 2023 | 97.78 Mn |
| Sep 30, 2023 | 96.56 Mn |
| Jun 30, 2023 | 94.88 Mn |
| Mar 31, 2023 | 95.52 Mn |
| Dec 31, 2022 | 94.05 Mn |
| Sep 30, 2022 | 93.53 Mn |
| Jun 30, 2022 | 92.10 Mn |
| Mar 31, 2022 | 91.78 Mn |
| Dec 31, 2021 | 91.30 Mn |
| Sep 30, 2021 | 90.84 Mn |
| Jun 30, 2021 | 92.03 Mn |